Literature DB >> 31950198

[S3 guidelines on gastric cancer-diagnosis and treatment of adenocarcinoma of the stomach and esophagogastric junction : Version 2.0-August 2019. AWMF register number: 032/009OL].

Stefan Mönig1, Katja Ott2, Ines Gockel3, Dietmar Lorenz4, Kaja Ludwig5, Helmut Messmann6, Markus Moehler7, Pompiliu Piso8, Arved Weimann9, Hans-Joachim Meyer10.   

Abstract

Entities:  

Year:  2020        PMID: 31950198     DOI: 10.1007/s00104-020-01112-y

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


× No keyword cloud information.
  4 in total

1.  [German S3-guideline "Diagnosis and treatment of esophagogastric cancer"].

Authors:  M Moehler; S-E Al-Batran; T Andus; M Anthuber; J Arends; D Arnold; D Aust; P Baier; G Baretton; J Bernhardt; H Boeing; E Böhle; C Bokemeyer; J Bornschein; W Budach; E Burmester; K Caca; W A Diemer; C F Dietrich; M Ebert; A Eickhoff; C Ell; J Fahlke; H Feussner; R Fietkau; W Fischbach; W Fleig; M Flentje; H E Gabbert; P R Galle; M Geissler; I Gockel; U Graeven; L Grenacher; S Gross; J T Hartmann; M Heike; V Heinemann; B Herbst; T Herrmann; S Höcht; R D Hofheinz; H Höfler; T Höhler; A H Hölscher; M Horneber; J Hübner; J R Izbicki; R Jakobs; C Jenssen; S Kanzler; M Keller; R Kiesslich; G Klautke; J Körber; B J Krause; C Kuhn; F Kullmann; H Lang; H Link; F Lordick; K Ludwig; M Lutz; R Mahlberg; P Malfertheiner; S Merkel; H Messmann; H-J Meyer; S Mönig; P Piso; S Pistorius; R Porschen; T Rabenstein; P Reichardt; K Ridwelski; C Röcken; I Roetzer; P Rohr; W Schepp; P M Schlag; R M Schmid; H Schmidberger; W-H Schmiegel; H-J Schmoll; G Schuch; C Schuhmacher; K Schütte; W Schwenk; M Selgrad; A Sendler; J Seraphin; T Seufferlein; M Stahl; H Stein; C Stoll; M Stuschke; A Tannapfel; R Tholen; P Thuss-Patience; K Treml; U Vanhoefer; M Vieth; H Vogelsang; D Wagner; U Wedding; A Weimann; H Wilke; C Wittekind
Journal:  Z Gastroenterol       Date:  2011-04-07       Impact factor: 2.000

2.  Pouch Versus No Pouch Following Total Gastrectomy: Meta-analysis of Randomized and Non-randomized Studies.

Authors:  Nicholas L Syn; Ian Wee; Asim Shabbir; Guowei Kim; Jimmy Bok-Yan So
Journal:  Ann Surg       Date:  2019-06       Impact factor: 12.969

3. 

Authors:  Markus Moehler; Salah-Edin Al-Batran; Tilo Andus; Jann Arends; Dirk Arnold; Gustavo Baretton; Jan Bornschein; Wilfried Budach; Severin Daum; Christoph Dietrich; Matthias Ebert; Wolfgang Fischbach; Michael Flentje; Ines Gockel; Lars Grenacher; Jörg Haier; Stefan Höcht; Rolf Jakobs; Christian Jenssen; Barbara Kade; Stefan Kanzler; Jost Langhorst; Hartmut Link; Florian Lordick; Dietmar Lorenz; Sylvie Lorenzen; Manfred Lutz; Helmut Messmann; Hans-Joachim Meyer; Stefan Mönig; Katja Ott; Michael Quante; Christoph Röcken; Peter Schlattmann; Wolff-H Schmiegel; Andreas Schreyer; Andrea Tannapfel; Peter Thuss-Patience; Arved Weimann; Susanne Unverzagt
Journal:  Z Gastroenterol       Date:  2019-12-11       Impact factor: 2.000

4.  Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.

Authors:  Salah-Eddin Al-Batran; Nils Homann; Claudia Pauligk; Thorsten O Goetze; Johannes Meiler; Stefan Kasper; Hans-Georg Kopp; Frank Mayer; Georg Martin Haag; Kim Luley; Udo Lindig; Wolff Schmiegel; Michael Pohl; Jan Stoehlmacher; Gunnar Folprecht; Stephan Probst; Nicole Prasnikar; Wolfgang Fischbach; Rolf Mahlberg; Jörg Trojan; Michael Koenigsmann; Uwe M Martens; Peter Thuss-Patience; Matthias Egger; Andreas Block; Volker Heinemann; Gerald Illerhaus; Markus Moehler; Michael Schenk; Frank Kullmann; Dirk M Behringer; Michael Heike; Daniel Pink; Christian Teschendorf; Carmen Löhr; Helga Bernhard; Gunter Schuch; Volker Rethwisch; Ludwig Fischer von Weikersthal; Jörg T Hartmann; Michael Kneba; Severin Daum; Karsten Schulmann; Jörg Weniger; Sebastian Belle; Timo Gaiser; Fuat S Oduncu; Martina Güntner; Wael Hozaeel; Alexander Reichart; Elke Jäger; Thomas Kraus; Stefan Mönig; Wolf O Bechstein; Martin Schuler; Harald Schmalenberg; Ralf D Hofheinz
Journal:  Lancet       Date:  2019-04-11       Impact factor: 79.321

  4 in total
  6 in total

Review 1.  Indication of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer (Gastripec, Gastrichip).

Authors:  Beate Rau; Linda Feldbrügge; Felix Gronau; Miguel Enrique Alberto Vilchez; Peter Thuss-Patience; Pierre Emmanuel Bonnot; Olivier Glehen
Journal:  Visc Med       Date:  2022-02-23

Review 2.  [Evidence in minimally invasive oncological gastric surgery].

Authors:  Kaja Ludwig; Christian Barz; Uwe Scharlau
Journal:  Chirurg       Date:  2021-04       Impact factor: 0.955

Review 3.  Oligometastatic Gastroesophageal Adenocarcinoma: Molecular Pathophysiology and Current Therapeutic Approach.

Authors:  Jin-On Jung; Henrik Nienhüser; Nikolai Schleussner; Thomas Schmidt
Journal:  Int J Mol Sci       Date:  2020-01-31       Impact factor: 5.923

Review 4.  Multimodal treatment in oligometastatic gastric cancer.

Authors:  Mickael Chevallay; Charles-Henri Wassmer; Pouya Iranmanesh; Minoa K Jung; Stefan P Mönig
Journal:  World J Gastrointest Oncol       Date:  2022-02-15

5.  RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV.

Authors:  Sylvie Lorenzen; Alexander Biederstädt; Ulrich Ronellenfitsch; Christoph Reißfelder; Stefan Mönig; Frederik Wenz; Claudia Pauligk; Martin Walker; Salah-Eddin Al-Batran; Bernhard Haller; Ralf-Dieter Hofheinz
Journal:  BMC Cancer       Date:  2020-09-15       Impact factor: 4.430

6.  Brain metastases in gastroesophageal cancers-an underestimated complication.

Authors:  Marius Brunner; Dominik Soll; Kathrin Adler; André Sasse; Ute König; Ardian Mekolli; Kristina Lowes; Johanna Reinecke; Volker Ellenrieder; Alexander König
Journal:  Gastric Cancer       Date:  2021-07-23       Impact factor: 7.370

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.